Lumeria Skin

Consumers buy skincare products but have no reliable way to know whether they are actually working on their wrinkles, acne, or inflammation. The page frames this as a $190B industry that runs on guessing rather than evidence. People lack access to the multi-spectrum imaging tools (UV fluorescence, polarized light) that clinics use to see sebum, pigmentation, and texture changes before they are visible on the surface, so they cannot tell which products or habits are helping versus which are setting their skin off.

Lumeria sells the Lumoscope, an at-home device that performs clinical-style multi-spectrum imaging of the skin under standardized lighting, working across skin tones, body parts, and ages. It captures UV fluorescence to surface pigment, sebum, and porphyrin patterns days before breakouts appear, and uses polarized imaging to cut surface glare so texture, pores, and vascularity can be compared consistently week to week. The companion software builds personalized routines, tracks fine lines, tone, and texture over time, includes an ingredient decoder covering 18,000 products, and offers an AI feature called 'Ask Lumi' that gives personalized answers based on the user's own scans. The company states explicitly that it offers insight and monitoring, not diagnosis, and is not a medical device.